Prevalence of anti-mycolic acid antibodies in patients with pulmonary tuberculosis co-infected with HIV

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 9, 2002, Pages 882-887

  Schleicher, Gunther K ^a   Feldman, Charles ^a   Vermaak, Yvonne ^a   Verschoor, Jan A ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Antibodies; Human immunodeficiency virus (HIV); Mycobacterium tuberculosis; Mycolic acid

Indexed keywords

BACTERIUM ANTIBODY; MYCOLIC ACID; BIOLOGICAL MARKER;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN SPECIFICITY; ARTICLE; BLOOD ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC ERROR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LABORATORY DIAGNOSIS; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RACE; SERODIAGNOSIS; T LYMPHOCYTE; ADOLESCENT; AGED; BLOOD; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; IMMUNOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; VIROLOGY;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; MYCOLIC ACIDS; TUBERCULOSIS, PULMONARY;

EID: 0036406815     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.156     Document Type: Article

References (30)

1. World Health Organization. Global Tuberculosis Control WHO Report 2000. WHO/CDS/TB/2000. Geneva: WHO, 2000.
2. Gennaro ML. Immunologic diagnosis of tuberculosis. Clin Infec Dis 2000; 30 (Suppl 3):S243-6.
3. Lyashchenko K, Colangeli R, Houde M, Aljahdali H, Menzies D, Gennaro ML. Heterogenous antibody responses in tuberculosis. Infect Immun 1998; 66:3936-40.
4. Daniel TM. Soluble mycobacterial antigens. In: Kubica GP, Wayne LGW, editors. The mycobacteria - a sourcebook. New York: Marcel Dekker Inc., 1984:417-65.
5. Misaki A, Azuma I, Yamamura Y. Structural and immunochemical studies on D-arabino-D-mannans and D-mannans of M. tuberculosis and other mycobacterial species. J Biochem 1987; 82:1759-70.
6. Brennan PJ. Antigenic peptidoglycolipids, phospholipids and glycolipids. In: Kubica GP, Wayne LGW, editors. The mycobacteria - a sourcebook. New York: Marcel Dekker Inc., 1984:467-89.
7. Arya SC. Serologic diagnosis of tuberculosis through assays of lipoarabinomannan antigen or antibody or lysozyme level. J Clin Microbiol 1993; 31:2836-7.
8. He H, Oka S, Han YK, Yamamura Y, Kusunose E, Kusunose M, et al. Rapid serodiagnosis of human mycobacteriosis by ELISA using cord factor purified from M. tuberculosis as antigen. FEMS Microbiol Immunol 1991; 3:201-4.
9. Han Y, Kawanda N, Yano I. Granuloma formation and in vitro macrophage activation in mice by mycoloyl glycolipids from Nocardia asteroids and related taxa. Osaka City Med J 1998; 44:201-17.
10. Pan J, Fujiwara N, Oka S, Maekura R, Ogura T, Yano I. Anticord factor IgG antibody in tuberculosis patients recognizes mycolic acid subclasses. Microbiol Immunol 1999; 43:863-9.
11. Goodrum MA, Siko DGR, Niehues T, Eichelbauer D, Verschoor JA. Mycolic acids from Mycobacterium tuberculosis: purification by countercurrent distribution and T-cell stimulation. Microbios 2001; 106:55-67.
12. Simonney N, Molina JM, Molimard M. Circulating immune complexes in human tuberculosis sera: demonstration of specific antibodies against M. tuberculosis glycolipid (DAT, PGLTb1, LOS) antigens in isolated immune complexes. Eur J Clin Invest 1997; 27:128-34.
13. Lilienfeld AM. Accuracy and reproducibility of examinations, including screening and diagnostic tests. In: Lilienfeld AM, Lilienfeld DE, editors. Foundations of epidemiology. New York: Oxford University Press, 1976:130-4.
14. Arloing S. Agglutination de bacille de la tuberculose vraie. Compt Rendu Acad Sci 1898; 126:1389-400.
15. Grange JM. The humoral immune response in tuberculosis: its nature, biological role, and diagnostic usefulness. Adv Tuberc Res 1984; 21:1-78.
16. Somi GR, O'Brien RJ, Mfinanga GS, Ipuye YA. Evaluation of the MycoDot test in patients with suspected tuberculosis in a field setting in Tanzania. Int J Tuberc Lung Dis 1999; 3:231-8.
17. Ratanasuwan W, Kreiss JK, Nolan CM, Schaeffler BA, Suwanagod S, Tansupasawasdikul S, et al. Evaluation of the MycoDot test for the diagnosis of tuberculosis in HIV-seropositive and -seronegative patients. Int J Lung Dis 1997; 1:259-64.
18. Lawn SD, Frimpong EH, Nyarko E. Evaluation of a commercial immunodiagnostic kit incorporating lipoarabinomannan in the serodiagnosis of pulmonary tuberculosis in Ghana. Trop Med Int Health 1997; 2:978-81.
19. Small PM, Perkins MD. More rigor needed in trials of new diagnostic agents for tuberculosis. Lancet 2000; 356:1048-9.
20. Perkins MD. New diagnostic tools for tuberculosis. Int J Tuberc Lung Dis 2000; 4:5182-8.
21. Maekura R, Nakagawa M, Nakamura Y, Hiraga T, Yamamura Y, Ito M, et al. Clinical evaluation of rapid serodiagnosis of pulmonary tuberculosis by ELISA with cord factor as antigen purified from M. tuberculosis. Am Rev Respir Dis 1993; 148:997-1001.
22. Fujiwara N, Pan J, Enomoto K, Terano Y, Honda T, Yano I. Production and partial characterization of anti-cord factor IgG antibody in rabbits recognizing mycolic acid sub-classes of M. tuberculosis or M. avium. FEMS Immunol Med Microbiol 1999; 24:141-9.
23. Simonney N, Molina JM, Molimard M, Oksenhendler E, Perronne C, Lagrange PH. Analysis of the immunological humoral responses to the M. tuberculosis glycolipid antigens (DAT, PGLTb1) for diagnosis of tuberculosis in HIV-seropositive and -seronegative patients. Eur J Clin Microbiol Infect Dis 1995; 14:883-91.
24. Harrington JJ, Ho JL, Lapa e Silva JR, Conde MB, Kritski AL, Fonseca LS, et al. M. tuberculosis lipid antigens: use of multiantigen based immunoassay for free and complex dissociated antibodies. Int J Tuberc Lung Dis 2000; 4:161-7.
25. Kremer L, Banlard AR, Besra GS. Genetics of mycolic acid biosynthesis. In: Hatfull GF, Jacobs WR, editors. Molecular genetics of mycobacteria. Washington, DC: ASM Press, 2000:173-85.
26. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. Recognition of a lipid antigen by CD1-restricted alpha beta-positive T-cells. Nature 1994; 372:691-4.
27. Dubnau E, Chan J, Raynaud C, Mohan VP, Lanéelle M-A, Yu K, et al. Oxygenated mycolic acids are necessary for virulence of M. tuberculosis in mice. Mol Microbiol 2000; 36:630-7.
28. Sieling PA, Ochoa MT, Jullien D, Leslie DS, Sabet S, Rosat JP, et al. Evidence for human CD4 T- cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T-cells from leprosy lesions. J Immunol 2000; 164:4790-6.
29. Alving CR, Wassef NM. Naturally occurring antibodies to cholesterol: a new theory of LDL cholestrol metabolism. Immun Today 1999; 20:362-6.
30. Dijksra J, Swartz GM, Raney JJ, Aniagolu J, Toro L, Nacy CA, et al. Interaction of anti-cholesterol antibodies with human lipoproteins. J Immunol 1996; 157:2006-13.